Navigation Links
Study of concurrent radiotherapy, chemotherapy shows promise in small cell lung cancer
Date:11/3/2009

tasis is still too high."

A previous phase III study conducted at M. D. Anderson and other sites through the North America Intergroup, showed accelerated fractionated radiotherapy (treatment in which radiation levels are increased over time) with concurrent VP-16 (etoposide) and cisplatin (platinum-based drugs) improved five-year survival rates. But this treatment often causes other side effects.

"Severe inflammation of the lining of the esophagus, also known as acute esophagitis, is a significant risk in this type of treatment," Komaki said. "Therefore, despite its long-term survival benefit, this modality has not been popular in community hospitals."

"Boosts" increase radiation levels

Researchers at M. D. Anderson and their colleagues developed this new study to find a way to increase the level of radiation during concurrent chemotherapy without increasing damage to normal tissue. Supported by NCI grant, this clinical study was then proposed to the Radiation Therapy Oncology Group (RTOG).

Patients with LSCL were treated with thoracic radiotherapy that was accelerated slowly over three weeks. The next step included two weeks of higher radiation levels twice daily, for a total of five weeks. During radiotherapy, patients received four cycles of chemotherapy.

"We gave the patients boosts of radiation twice a day in the last two weeks of treatment, when resistant cells often start to proliferate," Komaki said.

During the median follow-up time of 19 months, 41 percent of patients experienced complete response, and another 39 percent had partial response. Despite the higher radiation dose, the rate of acute severe esophagitis was significantly lower than the previous study, 18 percent, vs. 27 percent, respectively.

However, at 36.6 percent, the two-year survival rate did not improve. In addition, while local control of the disease was excellent, 80 percent, the majority of patients still deve
'/>"/>

Contact: Laura Sussman
lsussman@mdanderson.org
713-745-2457
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

1

GOOD

Page: 1 2 3

Related medicine news :

1. New national study finds increasing number of injuries from hot tubs
2. CDC Study Links 2 Antibiotics to Birth Defects
3. Fred Hutchinson Cancer Research Center Seeks Seattle Area Volunteers for a Stress-reduction Study
4. Study reveals second pathway to feeling your heartbeat
5. New Study Finds Shock-Wave Therapy for Unhealed Fractured Bones as Effective as Surgery
6. AEterna Zentaris Announces Positive Preliminary Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Ovarian Cancer
7. Data Supporting Boceprevir Response Guided Therapy Presented at American Association for the Study of Liver Diseases (AASLD) Annual Meeting
8. Study spotlights efficacy of questionnaire to identify patients at high risk for lung cancer
9. Study shows that sleep deprivation can negatively affect information processing
10. Study shows that sleep disturbances improve after retirement
11. Henry Ford Hospital study: A MRSA strain linked to high death rates
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Study of concurrent radiotherapy, chemotherapy shows promise in small cell lung cancer
Study of concurrent radiotherapy, chemotherapy shows promise in small cell lung cancer
(Date:12/16/2009)... in cardiology. The idea of publishing an ESC Textbook ... cardiovascular imagers, is therefore long awaited. The textbook is ... patient rather than technology-based approach, helping clinicians to explain ... imaging. , The book is divided into sections ... cardiac imaging and its clinical use in all major ...
(Date:12/16/2009)... A diet rich in methionine, an amino acid ... garlic, lentils, onions, yogurt and seeds, can possibly ... to a study by Temple researchers. , The ... Amyloid-β formation and deposition in a mouse model ... Alzheimer Research . , "When methionine reaches too ...
(Date:12/16/2009)... survey of Fortune 1000 employers strongly indicates that wellness programs ... benefits. , ... Minneapolis, MN (PRWEB) ... companies reveals that 78 percent of employers have improved employee ... program. In the survey, conducted by Hallmark Insights, ...
(Date:12/16/2009)... to announce that Chris Wepfer and Jackie Kirby have been ... Traveler magazine’s 2009 Recruiters of the Year Showcase. This is ... and the first for Jackie. , ... ... healthcare staffing agency, is honored to announce that Chris Wepfer ...
(Date:12/16/2009)... Tyco International Ltd. (NYSE: TYC ) ... for election to the Tyco Board of Directors ... 10, 2010. ,, Daniels, 55, is Senior ... of International Business Machines Corporation. In this role, ... business operations consisting of outsourcing services, integrated technology ...
Breaking Medicine News(10 mins):Health News:The European Society of Cardiology Textbook of Cardiovascular Imaging puts patient at center 2Health News:The European Society of Cardiology Textbook of Cardiovascular Imaging puts patient at center 3Health News:Diet high in methionine could increase risk of Alzheimer's 2Health News:Hallmark Insights' Employer Survey Reveals Cost-Savings Benefits of Health & Wellness Programs 2Health News:Medical Solutions is Proud to Announce Chris Wepfer and Jackie Kirby as the Company's Recruiter of the Year Recipients 2Health News:Medical Solutions is Proud to Announce Chris Wepfer and Jackie Kirby as the Company's Recruiter of the Year Recipients 3Health News:Tyco International Files Preliminary Proxy Proposing Election of New Director 2
... Management Systems,Inc.(R) (HMS) announced today that it was selected ... financial solutions for the hospital and,its two rural health ... for the 26-bed hospital and 126-bed nursing home in ... them closer to an electronic,health record (EHR) for their ...
... 21 Healthcare Executive Colleen A. Cain has been elected ... effective January 1. She replaces Mike Noel who ... committee chair. Cain brings to her new role nearly three ... been a member of the SCAN board of directors since ...
... Med (IM), the leader in,inpatient practice management information ... development aims at aligning software,development directly with client,s ... , Rapid development delivers ... radically reducing the size and duration of iterations ...
... actual discrimination, , , WEDNESDAY, Jan. 21 (HealthDay News) -- ... and are, in various aspects of their life, ... people with schizophrenia in the United States and 26 ... making or keeping friends, 43 percent from family members, ...
... nation,s growing population of breast cancer survivors ages, many ... and heart disease, and they,ll need specialized care to ... therapies they received. They,ll also need screenings and advice ... , But many patients give low marks to the ...
... Mich. A synthetic chemical version of what male ... them into traps and foil the mating process of ... scientists. , Pheromones, chemical scents used to attract a ... MSU professor of fisheries and wildlife, has focused much ...
Other Medicine News:Health News:Yalobusha General Hospital Selects HMS to Provide Information Technology Infrastructure 2Health News:SCAN Health Plan Elects Colleen Cain New Board Chair 2Health News:Ingenious Med Adopts Rapid Software Development, Allowing Customers to Drive Product and Technology 2Health News:Ingenious Med Adopts Rapid Software Development, Allowing Customers to Drive Product and Technology 3Health News:People With Schizophrenia Say Bias Is Part of Their Lives 2Health News:Penn study: Breast cancer survivors call for more 'survivorship care' from primary care physicians 2Health News:Penn study: Breast cancer survivors call for more 'survivorship care' from primary care physicians 3Health News:Chemical come-on successfully lures lovesick lampreys to traps 2
(Date:12/16/2009)... 16 GlaxoSmithKline plc [GSK] (NYSE: ... an exclusive licensing agreement in the United States ... NB-001, a novel, patented compound representing the next ... by NanoBio, NB-001 provides significant antimicrobial activity against ... labialis . ,, Cold sores are a ...
(Date:12/16/2009)... WAYNE, N.J., Dec. 16 MAQUET ... technologies, today announced that it has signed ... Novation, the industry,s leading supply contracting company, ... (EVH) Systems. The VASOVIEW products assist healthcare ... blocked coronary arteries using only small incisions. ...
(Date:12/16/2009)... Inc., a new clinical stage company developing innovative ... on its novel GFPA NMDA receptor modulators, today ... meeting showed that its lead compound GLYX-13 demonstrated ... of the CNS-related side effects seen with other ... also showed that GLYX-13,s antidepressant effects were evident ...
Breaking Medicine Technology:GlaxoSmithKline and NanoBio Announce OTC Licensing Agreement for Cold Sore Treatment 2MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 2MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 3MAQUET Cardiovascular Awarded Three-Year Single Source Contract From Novation for VASOVIEW Endoscopic Vessel Harvesting Devices 4Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 2Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 3Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 4Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 5Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects 6ESCO Announces Major Contract Award for Its Thermoforming Business 54966 1ESCO Announces Major Contract Award for Its Thermoforming Business 54966 2Nostrils Compete to Relay Key Fragrance 54963 1Nostrils Compete to Relay Key Fragrance 54963 2Former GE Executive Joins Lifeclinic International 54960 1Former GE Executive Joins Lifeclinic International 54960 2
... N.J., Jan. 14 Genta,Incorporated (Nasdaq: GNTA ... (FDA) has extended its review of Genta,s appeal ... Application (NDA) that proposed the use,of Genasense(R) (oblimersen ... refractory chronic lymphocytic leukemia. The Company had,previously provided ...
... CVM ) reports financial results for the fiscal ... operating loss for fiscal year 2007 of $9,352,209,versus a ... The loss per,share for fiscal year 2007 was unchanged ... from operating activities used during the year was about,$4,890,100. ...
Other Medicine Technology:FDA Extends Review of Genasense(R) NDA Appeal in Chronic Lymphocytic Leukemia 2FDA Extends Review of Genasense(R) NDA Appeal in Chronic Lymphocytic Leukemia 3CEL-SCI Corporation Announces 2007 Financial Results 2CEL-SCI Corporation Announces 2007 Financial Results 3
Hemato-clad Hematocrit Tubes combine the precision of glass with the safety provided by a Mylar® overwrap. Now you can give your laboratory staff safety with no compromise in accuracy....
... Volcano's new VH IVUS technology uses ... simplified interpretation of ultrasound images and ... of each patient's atherosclerotic plaques. The ... component types: fibrous, fibro-fatty, dense calcium, ...
... Internet-based remote monitoring from Medtronic is changing ... follow-up care. Using their Medtronic CareLink Monitor ... conveniently send device information from their home ... web site, clinicians have the ability to ...
... Service provides clinically valuable, device-derived information ... failure to help specialty physicians discern ... are stable or deteriorating. For example, ... a Medtronic InSync Sentry™ CRT-D system ...
Medicine Products: